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The main objective of this paper by Martin Flück et al.,1
which was supported by a research grant from the Euro-
pean Society for Vascular Surgery, was to determine
whether stimulated expression of native focal adhesion ki-
nase (FAK) protects peripheral skeletal muscle from
inﬂammation, rhabdomyolysis, and cell death induced by
ischemiaereperfusion (IR). The originality of the work
consists of differentiating fast glycolytic muscle from slow
oxidative muscle. The main ﬁndings of the present investi-
gation support the hypothesis of a beneﬁcial effect of FAK
in ischemic skeletal muscle modulated by the oxidative
muscle phenotype.
As many readers of this journal will not be familiar with
the molecular mechanisms behind the study hypothesis,
particularly the interaction between FAK and reperfu-
sioneischemia salvage kinase (RISK), the authors intro-
duced their work with a ﬁgure showing the RISK pathway
via FAK.
In this study, somatic gene transfection by viral vector
was used to stimulate FAK, and correlation between FAK
stimulation, mitochondrial reserves, and markers of
reperfusion injury were evaluated at various time points
after IR.
Whereas IR injury has given rise to research efforts and
allocation of resources for heart disease, skeletal muscle has
always been more or less ignored, making the approach
of the authors much more innovative. That said, skeletal
muscle physiology is complicated by various phenotypes
with different forms of energy metabolism and suscepti-
bility to ischemia. The authors obviously struggle with this
challenge, and although parts of their presentation are
necessarily complex, it is worthwhile reading for a vascular
surgeon who is confronted with IR on a day to day basis. In
this model, the effects were assessed following 4 hours of
ischemia and 24 hours of reperfusion to induce an ischemic
lesion with sub-lethal reperfusion injury that couldDOI of original article: http://dx.doi.org/10.1016/j.ejvs.2014.11.011
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http://dx.doi.org/10.1016/j.ejvs.2014.12.020potentially be attenuated by a therapeutic intervention;
that is, the most sensitive window to evaluate potential
therapeutic effects.
The reader may be led to engage in further speculation
about the actual therapeutic interventions potentially
linked to this experimental work. In particular, there is ev-
idence to assume that human muscles might react similarly
and the limitations of pharmacological manipulation/upre-
gulation of these kinase cascades clearly appear. Therefore,
questions regarding “the similarity in response between
human and rat muscle” and drawbacks for “future therapy”
are relevant.
As the authors point out, there is a critical lack of infor-
mation on the time course and ﬁbre type dependence of
human skeletal muscles’ response to IR injury. This insufﬁ-
ciency reﬂects ethical constraints that prevent the insult
from being experimentally produced in man. Consequently,
it is understood and appreciated that innovation on this
topic mainly relies on preclinical studies.
The relevance of the investigated mechanism for humans
is supported by the similar function and ﬁbre type
composition of the studied hind limb muscles of rats and
man.2 For instance, the soleus muscle, which exerts anti-
gravity functions in all mammalian species, is mainly
composed of slow oxidative muscle ﬁbres in rat and
humans. Muscles in both rat and humans have been shown
to respond to a number of external stimuli and stressors
with a cellular response that alters, for instance, the mito-
chondrial phenotype.3,4 Of speciﬁc relevance in this regard
is the fact that the post-translational regulation of the FAK
molecule by muscle unloading is preserved in human and
rat species alike.5 FAK protein is inactivated during ischemia
in humans by impaired tissue oxygenation, while its pre-
activation counteracts IR injury in contractile as well as
non-contractile tissues.6
In this regard, an important output of this study is that
the damage response to IR may be graded in relation to
mitochondrial reserves and FAK protein levels in humans as
well.
The translational strength of the study is the realistic
emulation of arterial limb ischemia. Moreover, this model
theoretically allows intra-arterial application of therapeutic
agents during ischemia that could be relevant for future
experiments. In clinical reality, preconditioning before
Protective Effect of Focal Adhesion Kinase 315iatrogenic ischemia is theoretically feasible in many situa-
tions during peripheral revascularization.
Novel information, as exposed through animal studies
such as the one presented here, provide insight into the
mechanism of IR injury and salvage that can help to instruct
future clinical investigations. I assume this was also the
perception of the Society, when they decided to support
this work.
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